Navigation Links
Hotspur Technology's Novel 3-in-1 Angioplasty Balloon Successfully Achieves First Commercial Deployment
Date:12/23/2010

y – rather than having to repurpose a variety of legacy devices designed for other procedures," said Gwen Watanabe, president and CEO of Hotspur. "We are committed to responding to this need and bringing high quality and efficient devices to a very broad and currently underserved market." Watanabe indicated that, based on the company's analysis, there are as many of 800,000 procedures performed annually that could benefit from this multi- purpose approach to catheter design for the peripheral access market.

In addition to the IQCath, Hotspur has also gained 510(k) clearance for two additional innovative balloon technologies. The GPSCath™ Balloon Dilatation Catheter follows the lead of the IQCath Balloon Dilatation Catheter as a specialty two-in-one device that allows the physician to conduct angioplasty and inject fluid while maintaining guidewire position. The Keeper™ Embolectomy Catheter is another two-in-one device which integrates an embolectomy balloon with the ability to inject physician-specified fluids while maintaining guidewire position.

These products are commercially available and are based on Hotspur's unique technologies designed to potentially make dialysis access and peripheral vascular interventions that are less invasive for patients, less expensive and more efficient for staff and facilities.

The foundation of all three of Hotspur's first commercial devices is a unique and groundbreaking technology, known as the VisioValve™ injection system. This innovation utilizes a proprietary valve system that allows a physician to perform angioplasty or clot removal and perform an injection of physician-specified fluids without having to remove the guidewire or exchange devices. Hotspur expects to develop a variety of other treatment devices based on this technology.

AoutHotspurTechnologiesFounded in 2008 and located in Mountain View, California, Hotspur Technologies (

SOURCE Hotspur Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson Announces Novel Oral Contraceptive Approval
2. Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Antheras Investigational Novel Peptibody Agent
3. Anaphore Enters R&D Partnership with Mitsubishi Tanabe Pharma to Develop and Commercialize Novel Protein Pharmaceuticals for Autoimmune Disorders
4. Tanabe Research Labs Enters R&D Partnership with Anaphore to Develop Novel Protein Pharmaceuticals for Autoimmune Disorders
5. InfraReDx Announces Publication of a Case Report in Circulation Highlighting Novel Clinical Finding with LipiScan™ Coronary Imaging System
6. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
7. Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine
8. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
9. ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR)
10. The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion
11. Cocrystal Discovery Receives Awards for Its Novel Antiviral Drug Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced ... Global Industry Analysis, Size, Share, Growth, Trends And Forecast, ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... patients in order to treat dental impairments, for tooth ...
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... Fla. , Jan. 15, 2014  In an unprecedented effort to ... TB in ambulances and other transport vehicles, an advanced and portable ... rescue personnel for the first time. In order ... with these deadly pathogens, West Palm Beach ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2
... Medical Center is,seeking local residents with type 2 ... clinical study evaluating an investigational,device, the TANTALUS System. ... The TANTALUS System is an implantable device that ... eats. The primary objective of the,randomized, double-blind controlled ...
... Phase 3 Results Released at American Society of ... Genta,Incorporated (Nasdaq: GNTA ) announced the ... of patients in the Company,s randomized Phase,3 trial ... chronic lymphocytic leukemia (CLL). The new data show ...
Cached Medicine Technology:Vanderbilt Medical Center Seeks Middle Tennesseans with Type 2 Diabetes Who are Overweight for National Clinical Trial 2Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 2Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 3Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 5Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 6
(Date:7/10/2014)... Low-fat cheeses and cakes that are just as ... supermarket shelves, thanks to fresh insights into how ... and texture. , Funded by the Engineering ... at Heriot-Watt University and the University of Edinburgh ... into micro-particles and therefore closely mimic the behaviour ...
(Date:7/10/2014)... experience hot flashes are unlikely to talk much about ... suffering if they are willing to try an ... case study., After seven weeks of hypnotic relaxation therapy, ... prostate cancer surgery showed a drastic decrease not only ... sleep quality, according to the study., The Baylor study ...
(Date:7/9/2014)... -- The World Health Organization recommends that youth participate ... vigorous physical activity (MVPA) each day. Studies have ... school hours. Therefore, it stands to reason that ... In a new study scheduled for publication in ... time spent outdoors after school was positively associated with ...
(Date:7/9/2014)... For the first time, researchers have access to detailed ... uses health care. A new study, called Our Health ... unique challenges faced by urban Aboriginal people in Canada ... , The findings, published today in BMJ Open ... and the general population. , Researchers interviewed 554 First ...
(Date:7/9/2014)... Researchers at the Perelman School of Medicine at ... Park Cancer Institute have received an $8 million grant ... effects of photodynamic light therapy (PDT) in patients with ... that most often manifests itself in the lining of ... to asbestos. The grant will fund a clinical trial ...
Breaking Medicine News(10 mins):Health News:Great tasting low-fat cheeses and cakes could soon be on the menu 2Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 2Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 3Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 4Health News:Go play outside! Outdoor time promotes physical activity in youth 2Health News:Urban Aboriginal people face unique health challenges 2Health News:Penn mesothelioma program receives $8 million NCI grant 2
... are treated in an emergency department (ED) after being ... in another violent encounter soon afterward, according to a ... Academic Societies (PAS) annual meeting in Vancouver, British Columbia, ... adolescents growing up in urban environments, and many emergency ...
... Packard Children,s Hospital and Stanford University School of Medicine ... decrease in hospital-wide mortality rates can be associated with ... The system, launched at Packard Children,s in 2007, was ... at the hospital over an 18-month period, according to ...
... The United States ... recently announced a collaborative study to evaluate an increased risk of cancer among firefighters as ... ... States Fire Administration, or USFA, and the National Institute for Occupational Safety and ...
... cancer, researcher says , SUNDAY, May 2 (HealthDay News) -- ... can lead to severe liver damage later in life, a ... Miller School of Medicine noted that national data shows that ... the United States are infected with hepatitis C. Based on ...
... ... community of Westmont Living, Morgan Hill, CA. Westmont of Morgan Hill offers a ... or memory care. Our primary goal is always to meet each resident’s individual requirements, ... ...
... of Paget,s disease, a painful bone condition that affects up ... international team of scientists, led by the University of Edinburgh, ... which bone is repaired, providing an explanation of why the ... normal process of breaking down old bone and replacing it. ...
Cached Medicine News:Health News:Young assault victims often involved in subsequent violence 2Health News:Study shows for first time decrease in mortality associated with physician order entry system 2Health News:Study shows for first time decrease in mortality associated with physician order entry system 3Health News:Federal Agencies to Study Causes of Firefighters' Cancers 2Health News:Federal Agencies to Study Causes of Firefighters' Cancers 3Health News:Many Kids With Hepatitis C Are Missed 2Health News:Designer Makeover for a New Resident at Westmont of Morgan Hill 2Health News:Gene find offers hope of screening test for bone disease 2
Rosenbaum card fits in the pocket (3.5 by 6.5") and shows point, Jaeger and distance equivalents from 20/800 to 20/20. Uses numbers, directional Es and XO patterns. For use at 14" (35 mm). Includes f...
... contemporary reading card was designed by James ... of near point exercises including words, numbers ... 20/260, 20/200, 20/100, 20/65, 20/50, 20/40, 20/30, ... reading in English and metric, Jaeger, point ...
Standard reading test. "walked regularly..."...
Standard reading test. "Children should be..."...
Medicine Products: